title: Hypoxia induces downregulation of soluble guanylyl cyclase β1 by miR-34c-5p.
abstract: Soluble guanylyl cyclase (sGC) is the principal receptor for nitric oxide (NO) and crucial for the control of various physiological functions. The β1 subunit of sGC is obligatory for the biological stability and activity of the sGC heterodimer. MicroRNAs (miRNAs) are important regulators of gene expression and exert great influences on diverse biological activities. The aim of the present study was to determine whether or not the expression of sGCβ1 is specifically regulated by miRNAs. We report that miR-34c-5p directly targets sGCβ1 under hypoxia. Bioinformatics analysis of the sGCβ1 3'-untranslated region (3'-UTR) revealed a putative binding site for miR-34b-5p and miR-34c-5p, but only miR-34c-5p inhibited luciferase activity through interaction with sGCβ1 3'-UTR in HEK293T cells. Site-directed mutagenesis of the putative miR-34c-5p binding site abolished the negative regulation of luciferase expression. Overexpression of miR-34c-5p repressed the expression of sGCβ1 in stable cell lines, which was reversed by miR-34c-5p-specific sponge. Inoculation of mouse lung tissues in vitro with lentivirus bearing miR-34c-5p significantly decreased both the expression of sGCβ1 and NO-stimulated sGC activity, which was also rescued by miR-34c-5p-specific sponge. Furthermore, we identified the putative Sp1-binding site in the promoter region of miR-34c-5p. Luciferase reporter constructs revealed that Sp1 directly binds to the wild-type promoter of miR-34c-5p, which was confirmed by chromatin immunoprecipitation. In summary, these findings reveal that miR-34c-5p directly regulates sGCβ1 expression, and they identify the key transcription factor Sp1 that governs miR-34c-5p expression during hypoxia.
authors.affiliation: Department of Physiology and Pathophysiology, Peking University Health Science Center, Beijing, China.
authors.forename: Xiaojian
authors.initials: X
authors.lastname: Xu
authors.forename: Shumin
authors.initials: S
authors.lastname: Wang
authors.forename: Juan
authors.initials: J
authors.lastname: Liu
authors.forename: Dou
authors.initials: D
authors.lastname: Dou
authors.forename: Limei
authors.initials: L
authors.lastname: Liu
authors.forename: Zhengju
authors.initials: Z
authors.lastname: Chen
authors.forename: Liping
authors.initials: L
authors.lastname: Ye
authors.forename: Huixia
authors.initials: H
authors.lastname: Liu
authors.forename: Qiong
authors.initials: Q
authors.lastname: He
authors.forename: J Usha
authors.initials: JU
authors.lastname: Raj
authors.forename: Yuansheng
authors.initials: Y
authors.lastname: Gao
mesh_terms: D000818:Animals; D019556:COS Cells; D015687:Cell Hypoxia / Q000502:physiology*; D002478:Cells, Cultured; D002522:Chlorocebus aethiops; D015536:Down-Regulation; D005260:Female; D006162:Guanylate Cyclase / Q000235:genetics / Q000378:metabolism*; D057809:HEK293 Cells; D006801:Humans; D051379:Mice; D035683:MicroRNAs / Q000235:genetics / Q000378:metabolism*; D009131:Muscle, Smooth, Vascular / Q000166:cytology; D021122:Protein Subunits; D011897:Random Allocation; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics / Q000378:metabolism*; D000071756:Soluble Guanylyl Cyclase
chemical_list: C522425:MIRN34 microRNA, human; D035683:MicroRNAs; D021122:Protein Subunits; D018160:Receptors, Cytoplasmic and Nuclear; D006162:Guanylate Cyclase; D000071756:Soluble Guanylyl Cyclase